D104 - Framework for the Supply of Ready to Administer Products
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Deadline | 17 Jan 2025 |
| Contract start | 1 Jul 2025 |
| Contract end | 30 Jun 2027 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-02bd19cf-8f71-4ae7-b663-494f66a83321 |
Awards (2)
This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Fresenius Kabi Limited shared | £0 | 9 Apr 2025 | active |
| hameln pharma ltd shared | £0 | 9 Apr 2025 | active |
description
The East Midlands Pharmacy Collaborative (EMPC) as the Authority wishes to establish a multi-provider Framework Agreement for the Supply of Ready to Administer Products on behalf of its member Trusts
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 16 Apr 2025 | Award (award) | · | 5b473ec0-1eb8-4dbe-b69d-fa7fa3ddf83e-840937 |
more from East Midlands Pharmacy Collaborative
- Framework Agreement for the Provision of Dose Banded Chemotherapy Services · 22 Jun 2026
- D102 - Framework Agreement for the Provision of a Mid- Tech Homecare Service for the Dispensing and Home Delivery of Self-Injecting and Self-Infused Products (including Pharma Funded Schemes) and removal of waste · £1 · 26 Jun 2025
- Framework for the provision of a Low-Tech Dispense and Delivery Service · 19 Mar 2025
- Framework Agreement for the Provision of a Low-Tech Homecare Dispense and Delivery Service · £1,500,000 · 19 Mar 2025
- Framework for a Mid-Tech Homecare Service · £8,000,000 · 29 Nov 2024
- Framework for High-Tech Homecare Services - IVAB/OPAT · £6,000,000 · 25 Nov 2024
- Supply of Ready to Administer Products · £3,200,000 · 11 Nov 2024
- Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies · £2,760,000 · 9 Aug 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.